Reliance Global Group Signs Term Sheet to Acquire Controlling Interest in Enquantum
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3d ago
0mins
Reliance Global Group announced that it has entered into a non-binding term sheet to acquire a controlling interest in Enquantum. In addition, in connection with the term sheet, On January 15, 2026, Reliance executed a secured promissory note as an advance of the initial funding under a definitive agreement, if executed. The Promissory Note is secured by all of the assets of Enquantum and payable within 60 days of its issuance date if a definitive agreement is not entered into. If a definitive agreement is entered into, the balance due under the Promissory Note will be applied against the first two payment milestones.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on RELI
About RELI
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. It focuses on growing by pursuing acquisition strategies and focused on wholesale and retail insurance agencies. Its business-to-business InsurTech platform, RELI Exchange, provides independent insurance agencies with an entire suite of business development tools. Its business-to-consumer platform, 5minuteinsure.com (5MI), utilizes artificial intelligence and data mining to provide online insurance quotes within minutes to everyday consumers seeking to purchase auto, home, and life insurance. It has added Ethereum to its financial holdings. It focuses on identifying specific risk to reward arbitrage opportunities and developing these on a national platform, and identifying and acquiring undervalued wholesale and retail insurance agencies with operations in growing or underserved segments. It owns Solana, the native token of the Solana blockchain.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Reliance Global Group to Acquire Controlling Interest in Enquantum Ltd.
- Acquisition Plan: Reliance Global Group has entered a non-binding term sheet with Enquantum to pursue a controlling interest through a structured investment process over the next 12 months, addressing the emerging threat of quantum computing to encryption security.
- Funding Arrangement: The company executed a secured promissory note on January 15, 2026, as an advance for initial funding, which must be repaid within 60 days if a definitive agreement is not reached, reflecting confidence in the transaction while maintaining structural protections.
- Market Outlook: The post-quantum cryptography market is projected to reach $2.84 billion by 2030, as new cybersecurity regulations come into effect, forcing organizations to upgrade their technology to mitigate risks posed by quantum computing.
- Technological Advantage: Enquantum focuses on developing NIST-compliant post-quantum cryptographic hardware cores designed to deliver higher speed and security, enabling organizations to transition to post-quantum security without compromising operational efficiency.
Continue Reading
Reliance Global Changes Ticker to EZRA, Focuses on Tech Acquisitions
- Ticker Change: Reliance Global is changing its NASDAQ ticker from 'RELI' to 'EZRA' effective January 26, aiming to better reflect its strategic evolution and potentially enhance market recognition and investor confidence.
- New Division Launch: The formation of EZRA International Group focuses on acquiring controlling stakes and accelerating the growth of breakthrough technology companies, emphasizing sectors like cybersecurity, artificial intelligence, and data analytics, indicating the company's commitment to the tech market.
- Acquisition Plan Initiated: Reliance Global plans to acquire a majority stake in Scentech, an AI diagnostics firm developing non-invasive breath-based disease detection technologies, marking its first acquisition under the new strategy and promising significant long-term growth potential.
- Clear Strategic Goals: By structuring the acquisition around clinical, regulatory, and operational milestones, Reliance Global demonstrates its intention to pursue high-impact, technology-driven opportunities, further solidifying its market position in the tech sector.
Continue Reading